Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-07

Clinical Trial Update: Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 study evaluating RSVpreF vaccination with an RSV challenge in healthy adults has completed, and results were posted on 2024-08-07.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RSVpreF

Snippet

Sponsor: Hvivo | Conditions: Respiratory Syncytial Virus Infections | Phase 2 | Status: COMPLETED | Results posted: 2024-08-07